
HealthOn Review
Best for: compounded GLP-1 access
HealthOn offers compounded semaglutide and tirzepatide starting at $155/month. Multi-category telehealth platform covering weight loss, sexual health, longevity, and hair health.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
HealthOn is a solid telehealth option with balanced features and pricing.
HealthOn at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $189/mo (Starting at $189; lowest on the 12-month plan)
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored HealthOn
Each dimension is scored algorithmically from HealthOn’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.6/10At $189/mo, HealthOn runs about 11% above the $170 median for GLP-1 providers.
Effectiveness25%
7.9/10HealthOn offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
7.8/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
5.9/10HealthOn's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.7/10HealthOn provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this HealthOn review
Last checked 2026-06-06- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications HealthOn offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides HealthOn offers
Beyond GLP-1s, HealthOn also offers these peptides — tap any for our evidence-based guide.
Pricing
Starting at $189; lowest on the 12-month plan
Starting at $290; lowest on the 12-month plan
Ready to get started?
Plans and promotions change often — check HealthOn's current pricing and active discounts before you decide.
What we like
- Both compounded semaglutide and tirzepatide available
- Weight-loss pricing starts at $189/mo for compounded semaglutide
Watch-outs
- No visible LegitScript certification or PCAB accreditation
- State availability not publicly disclosed
- Lowest advertised prices require a 12-month plan commitment
HealthOn review: a low entry price for compounded GLP-1, with some gaps to weigh
HealthOn is a multi-category telehealth shop that sells compounded semaglutide and tirzepatide alongside sexual-health, longevity, and hair products. For weight loss specifically, its appeal is simple: the advertised starting price is one of the lower ones in the compounded category, at $189 a month versus a category median of $170. If your main goal is getting a legitimate-looking GLP-1 subscription for as little as possible, HealthOn is worth a look. But the low number comes with a commitment, and the company is quieter than we'd like about a few things that matter for safety and eligibility.
How the pricing actually works
The headline $189 per month is the cheapest tier, and you only get there by signing up for the 12-month plan. HealthOn frames its savings as 'up to' a few hundred dollars off the year-long commitment for semaglutide, and a slightly different amount off for tirzepatide, which starts higher at the equivalent of roughly the high-two-hundreds per month. Compounded tirzepatide is always the pricier of the two molecules here, as it is almost everywhere.
There's also a subscription mechanic worth understanding before you click buy. HealthOn bills and ships quarterly: you're charged every three months and the medication arrives in those same batches. The company's own language is that this is how you 'lock in the lowest cost per dose.' That's fine if you're committed, but it means you're effectively pre-paying a quarter at a time, and the very lowest rate assumes you stay for a full year. If you want a true month-to-month trial with no long commitment, this isn't really that.
- Semaglutide: starts at $189/mo on the 12-month plan
- Tirzepatide: starts higher, in the high-two-hundreds per month on the 12-month plan
- Billing: quarterly — charged and shipped every three months
- Lowest price: requires the year-long commitment
What's actually included
HealthOn says its pricing is 'all-inclusive' with 'no hidden fees,' and the displayed price is the medication subscription itself — for semaglutide that's described as up to 1.5mg monthly. Shipping is folded in, advertised as free and discreet with one-to-two-day delivery. So the number you see is meant to be close to the number you pay, which is a genuine plus in a category where surprise consult fees and dose-escalation upcharges are common.
The medications and how they're dispensed
Both products are compounded, not brand-name. From the product imagery our editors verified, the semaglutide is a 5mg/mL formulation and the tirzepatide is 20mg/mL. These are injectables shipped to your door, and there's no oral or brand-name option on the menu. If you specifically want FDA-approved Wegovy or Zepbound, HealthOn isn't your provider — this is a compounded-only shop, which is exactly why the price can sit where it does.
The thing that gives us pause
Two gaps stand out. First, we couldn't find a LegitScript certification or PCAB accreditation displayed anywhere on the site, and the compounding pharmacy behind the products isn't named. In a category where the better operators put their pharmacy credentials front and center, that silence is a real mark against HealthOn rather than a neutral detail. Second, HealthOn doesn't publicly disclose which states it serves, so you may not know whether you're eligible until you're partway through signup.
There's also a quirk our team caught: HealthOn's product-page template appears to share copy and infrastructure with Eden, another telehealth brand — one disclaimer even references Eden by name. That doesn't prove anything is wrong, but it suggests HealthOn may be running on a white-label or shared platform rather than its own fully built-out medical operation. Read it as a reason to ask questions, not a verdict.
Who it's for — and who should skip it
HealthOn makes sense if you're price-driven, comfortable with compounded medication, ready to commit to a longer plan, and you've already confirmed you can be served in your state. The low entry price and all-inclusive billing are the real draws.
Skip it if you want brand-name GLP-1, prefer true month-to-month flexibility, or — most importantly — if visible pharmacy accreditation is a dealbreaker for you. Patients who want to see a LegitScript badge and a named, accredited pharmacy before handing over a card should choose a provider that publishes those credentials openly.
Trust and medical oversight
To be clear about confidence: there are no FDA warning letters on file for HealthOn in our records, which is good. But the absence of a problem isn't the same as proof of strong oversight. The missing accreditation badges, the undisclosed pharmacy, and the shared-template signal mean we can't vouch for the depth of HealthOn's medical operation the way we can for providers that show their work. Our take is cautious-positive on price, neutral-to-skeptical on transparency. You can read how we weigh these factors in our scoring methodology.
Bottom line
HealthOn delivers a genuinely competitive starting price on compounded semaglutide and tirzepatide, with all-inclusive billing and free shipping baked in. For budget-focused patients willing to commit to a longer plan, that's a real offer. The catch is everything HealthOn doesn't show you: no visible accreditation, no named pharmacy, no public state list, and a product template that looks borrowed from another brand. If you go in with eyes open and confirm eligibility first, it can work — but it earns a 'verify before you buy' rather than an unreserved recommendation.
For a side-by-side, Bodybuilding Health+ ($179/month) and RNK Health ($197/month) are the most comparable options to weigh against HealthOn.
Ready to start with HealthOn?
Starting at $189/month. See current pricing and start your free consultation.
HealthOn might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to HealthOn
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HealthOn review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with HealthOn?
Starting at $189/month. See current pricing and start your free consultation.